Marked mucosal lipid shifts in treatment refractory inflammatory bowel disease: a lipidomic study
Mechanisms causing non-response to biological agents in IBD remain to be fully understood. Thus, we aimed to characterize the lipid profile in treatment refractory non-immunogenic patients with adequate trough...